Endocrine signaling research
GHRP-6
Lyophilisiertes Peptid zur Forschung zu endokrinen Signalen zur Systemüberprüfung
GHRP-6 is an early growth hormone releasing peptide used as a reference point in GH secretagogue literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesNur für Laborforschungszwecke. Nicht für den menschlichen oder veterinärmedizinischen Gebrauch bestimmt. Nicht zur Diagnose, Behandlung, Heilung, Linderung oder Vorbeugung von Krankheiten bestimmt.
Verschlossen, kalt, trocken und vor Hitzeschwankungen geschützt aufbewahren. Bestätigen Sie die produktspezifische Lagerung bei der Ankunft.
Verpackt für Transportstabilität mit Bestellunterstützung für Routen bei warmem Wetter.
Batch-linked certificate support is available through the documentation desk.
Forschungskontext
GHRP-6 Forschungsprofil
GHRP-6 is an early synthetic growth hormone-releasing peptide used as a reference in ghrelin-receptor and GH-secretagogue research. Experimental studies measure GH response, receptor signaling, endocrine markers, appetite-related pathways, and differences from GHRP-2, ipamorelin, hexarelin, or GHRH analogs. It is commonly chosen when a project needs a historically established GHS-R comparator with a broad physiological research record. Because secretagogues can differ in selectivity and off-target endocrine observations, compounds should not be treated as interchangeable. Findings from older human or animal studies describe their specific materials and protocols and do not establish the suitability or performance of a separate catalog product.
Vorgeschlagener Mechanismus
A synthetic GHS-R1a agonist that stimulates growth-hormone release and activates central ghrelin-related appetite pathways. It also has measurable endocrine activity beyond GH in some models.
In Studien berichtete Effekte
- Human and animal studies reported acute GH release and increased food intake or appetite-related signaling.
- Some studies observed increases in cortisol or prolactin, demonstrating lower endocrine selectivity than a purely GH-specific ligand.
- Responses can diminish or change with repeated exposure and depend on endogenous GHRH and somatostatin tone.
Häufige Forschungsendpunkte
GHS-R activation, GH, ACTH, cortisol, prolactin, food intake, hypothalamic signaling, glucose, receptor desensitization, and interaction with GHRH.
Evidenz und Grenzen
The acute endocrine and appetite-related effects are documented in preclinical and human pharmacology studies. Long-term safety and product equivalence remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
What documentation can I request before ordering?
Before ordering, contact support with the product name, selected format, andu2014if availableu2014an order or batch reference to request available batch-linked documentation.
What should I confirm before ordering?
Compare the product name, listed amount, physical form, storage note, price, and documentation route. When the order arrives, match the product and lot or batch reference to the order record and available documentation.